柴胡三神煎治疗气郁痰瘀型肺结节的临床疗效研究

Objective To investigate the clinical efficacy of Chaihu Sanshen Decoction in the treatinent of pulmonary nodules qi-stagnation and phlegm-stasis syndrome. Methods Using the random number table method, 200 patients with qi-stagnation and phlegm-stasis syndrome pulmonary nodules who were treated at the outpatient department of the Affiliated Hospital of Traditional Chinese Medicine of Chongqing Three Gorges Medical College from February 2023 to June 2025 were divided into a control group and a treatment group, with 100 cases in each group. The control group was given pulmonary nodule health education combined with chest CT examination, while the treatment group was treated with Chaihu Seshen Decoction on the basis of the treatment of the control group. The TCM syndrome scores and CT imaging results of the two groups before and after treatment were compared to analyze the clinical efficacy. Results Following treatment, the overall response rate in the treatment group was higher than that in the control group(P<0.05). Compared with the control group, the treatment group showed a more marked reduction in intermittent coughing, sputum production, discomfort in the chest and flanks, restlessness, a sticky sensation in the mouth, and wind-heat accumulation(P<0.05). Following treatment, the treatment group exhibited a more marked reduction in diameter and area compared with the control group(P<0.05). Conclusion Chaihu Sanshen Decoction can effectively treat patients with pulmonary nodules of qi-stagnation and phlegm stasis syndrome, with obvious therapeutic effects.